Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue
Sono-Tek (NASDAQ: SOTK) reported second quarter and first half fiscal 2026 results for the period ended August 31, 2025, highlighting record first-half revenue of $10.30M and six consecutive quarters with >$5M quarterly sales. H1 net income rose 35% to $909K and Q2 net income increased 24% to $424K. Gross margin expanded to 51% (H1) and 50% (Q2), aided by favorable product mix and warranty expense. Cash, cash equivalents and marketable securities totaled $10.6M with no debt. Total equipment and service backlog was $11.21M, up 50% sequentially, driven by strong medical-market orders including ~$5M and ~$2.8M medical orders cited. Company updated FY26 guidance to modest revenue growth while noting tariff and clean-energy policy headwinds offset by medical demand.
Sono-Tek (NASDAQ: SOTK) ha riportato i risultati del secondo trimestre e della prima metà dell'anno fiscale 2026 per il periodo terminato il 31 agosto 2025, evidenziando un fatturato record della prima metà di 10,30 milioni di dollari e sei trimestri consecutivi con vendite trimestrali superiori a 5 milioni di dollari. L’utile netto della H1 è aumentato del 35% a 909k dollari e l’utile netto del Q2 è salito del 24% a 424k dollari. Il margine lordo è cresciuto al 51% (H1) e 50% (Q2), grazie a una favorevole combinazione di prodotto e alle spese di garanzia. La cassa, i contanti e i titoli negoziabili ammontano a 10,6 milioni di dollari senza debiti. Il backlog totale di apparecchiature e servizi era di 11,21 milioni di dollari, in aumento del 50% rispetto al trimestre precedente, trainato da forti ordini nel mercato medico, inclusi ordini per circa 5 milioni di dollari e circa 2,8 milioni di dollari citati. L’azienda ha aggiornato le previsioni per FY26 a una crescita modesta dei ricavi, pur osservando che gli ostacoli tariffari e le politiche sull’energia pulita sono stati compensati dalla domanda medica.
Sono-Tek (NASDAQ: SOTK) presentó los resultados del segundo trimestre y del primer semestre del año fiscal 2026 para el periodo terminado el 31 de agosto de 2025, destacando ingresos récord del primer semestre de 10,30 millones de dólares y seis trimestres consecutivos con ventas trimestrales superiores a 5 millones de dólares. La utilidad neta del H1 aumentó un 35% a 909 mil dólares y la utilidad neta del Q2 creció un 24% a 424 mil dólares. El margen bruto se expandió a 51% (H1) y 50% (Q2), gracias a una mezcla de productos favorable y a los gastos de garantía. El efectivo, equivalentes de efectivo y valores negociables totalizaron 10,6 millones de dólares sin deuda. El backlog total de equipos y servicios fue de 11,21 millones de dólares, un 50% más secuencialmente, impulsado por fuertes pedidos en el mercado médico, incluidos ~5 millones de dólares y ~2,8 millones de dólares en pedidos médicos citados. La compañía actualizó las perspectivas para FY26 a un crecimiento modesto de los ingresos, señalando al mismo tiempo vientos en contra por aranceles y políticas de energía limpia, compensados por la demanda médica.
Sono-Tek(나스닥: SOTK)는 2025년 8월 31일 종료된 기간에 대한 2026 회계 연도 2분기 및 상반기 실적을 발표했으며, 상반기 매출은 기록적인 1,030만 달러를 기록했고 6개 분기에 걸쳐 매 분기 500만 달러 이상의 매출을 달성했습니다. H1 순이익은 35% 증가한 90.9만 달러이고 Q2 순이익은 24% 증가한 42.4만 달러입니다. 총이익률은 H1 51% 및 Q2 50%로 확대되었으며, 이는 우호적인 제품 구성과 보증비용 덕분입니다. 현금 및 현금등가와 시장성 증권은 1,060만 달러로 부채가 없습니다. 총 장비 및 서비스 백로그는 11.21백만 달러로 전분기 대비 50% 증가했으며, 의료 시장의 강한 주문에 힘입어 약 500만 달러 및 280만 달러의 의료 주문이 언급되었습니다. 회사는 FY26 가이던스를 매출 성장의 완만한 증가로 업데이트했으며, 관세 및 친환경 정책의 역풍이 의료 수요로 상쇄되었다고 밝혔습니다.
Sono-Tek (NASDAQ: SOTK) a publié les résultats du deuxième trimestre et du premier semestre de l’exercice 2026 pour la période se terminant le 31 août 2025, mettant en évidence un chiffre d’affaires record du premier semestre de 10,30 M$ et six trimestres consécutifs avec des ventes trimestrielles supérieures à 5 M$. Le résultat net du H1 a augmenté de 35% à 909 k$ et le résultat net du Q2 a augmenté de 24% à 424 k$. La marge brute s’est étendue à 51% (H1) et 50% (Q2), aidée par une combinaison de produits favorable et les dépenses de garantie. La trésorerie, les équivalents de trésorerie et les valeurs mobilières totalisent 10,6 M$ sans dette. Le carnet d’ordres total d’équipements et de services était de 11,21 M$, en hausse de 50% d’une période à l’autre, porté par de solides commandes dans le marché médical, dont environ 5 M$ et 2,8 M$ de commandes médicales citées. La société a révisé ses prévisions FY26 à une croissance modeste du chiffre d’affaires, tout en constatant que les vents contraires des tarifs et des politiques d’énergie propre ont été compensés par la demande médicale.
Sono-Tek (NASDAQ: SOTK) hat die Ergebnisse des zweiten Quartals und des ersten Halbjahres des Geschäftsjahres 2026 für den Zeitraum zum 31. August 2025 gemeldet und einen Rekordumsatz im ersten Halbjahr von 10,30 Mio. USD sowie sechs aufeinander folgende Quartale mit Quartalsumsätzen über 5 Mio. USD verzeichnet. Das Nettoergebnis im H1 stieg um 35% auf 909 Tsd. USD und das Nettoergebnis im Q2 um 24% auf 424 Tsd. USD. Die Bruttomarge expandierte auf 51% (H1) und 50% (Q2), unterstützt durch eine günstige Produktmix und Garantiekosten. Barbestände, Zahlungsmittel und marktfähige Wertpapiere beliefen sich auf insgesamt 10,6 Mio. USD ohne Schulden. Der Gesamtauftragsbestand für Ausrüstung und Service betrug 11,21 Mio. USD, was einem sequenziellen Anstieg von 50% entspricht und von starken Bestellungen im medizinischen Markt getrieben wurde, darunter ca. 5 Mio. USD und 2,8 Mio. USD medizinische Aufträge. Das Unternehmen aktualisierte die FY26-Prognose auf ein modertes Umsatzwachstum, stellte jedoch fest, dass Zölle und politische Vorgaben im Bereich saubere Energie durch die medizinische Nachfrage ausgeglichen wurden.
Sono-Tek (NASDAQ: SOTK) أعلنت عن نتائج الربع الثاني ونصف السنة المالية 2026 للفترة المنتهية في 31 أغسطس 2025، مع إبراز إيراداتٍ قياسية للنصف الأول بلغت 10.30 مليون دولار وستة أرباع متتالية بأكثر من 5 ملايين دولار من المبيعات الربع سنوية. ارتفع صافي الدخل للنصف الأول بنسبة 35% إلى 909 آلاف دولار، وازداد صافي دخل الربع الثاني بـ24% إلى 424 ألف دولار. توسع هامش الربح الإجمالي إلى 51% (النصف الأول) و50% (الربع الثاني)، بمساعدة مزيج المنتجات الملائم وتكاليف الضمان. بلغ النقد وما في حكمه من نقد وأوراق مالية قابلة للتسييل 10.6 مليون دولار، دون ديون. كان إجماليُ مخزون المعدات والخدمات 11.21 مليون دولار، بزيادة 50% على أساس ثنائي، مدفوعاً بطلبات قوية في السوق الطبي بما في ذلك نحو 5 ملايين دولار و2.8 مليون دولار من الطلبات الطبية المذكورة. قامت الشركة بتحديث توجيهات FY26 نحو نمو معتدل في الإيرادات مع الإشارة إلى أن ضغوط الرسوم وسياسات الطاقة النظيفة تم تعويضها بارتفاع الطلب الطبي.
Sono-Tek（纳斯达克股票代码：SOTK） 公布了截至 2025 年 8 月 31 日止 period 的 2026 财年第二季度及上半年的业绩，显示上半年收入创纪录为 1030 万美元，并且实现了六个季度连续性季度销售超过 500 万美元。上半年净利润同比增长 35% 至 90.9 万美元，第二季度净利润增长 24% 至 42.4 万美元。毛利率扩展至 51%（上半年） 与 50%（Q2），得益于有利的产品组合与保修费用。现金及现金等价物和可变现证券总计 1060 万美元，无债务。设备与服务总 backlog 为 112.10 万美元，环比增长 50%，由强劲的医疗市场订单推动，包含约 500 万美元 与 280 万美元 的医疗订单。公司将 FY26 指引更新为温和的收入增长，同时表示关税及清洁能源政策的阻力被医疗需求所抵消。
- Record H1 revenue of $10.30M
- H1 net income +35% to $909K
- Backlog +50% sequentially to $11.21M
- Medical market sales +150% to $1.00M
- Cash and marketable securities $10.6M with no debt
- In-Line Coating Systems Q2 sales down 24% (-$493K)
- Industrial market Q2 sales down 68% (-$517K)
- US/Canada Q2 sales down 22% (-$775K)
- Multi-Axis systems H1 sales down 41% (-$1.89M)
Insights
Sono-Tek shows modest revenue growth, stronger profitability, and a materially larger backlog driven by medical orders.
Second quarter and first-half results show sustained revenue above
Key dependencies include the timing of clean energy-related customer orders and the growing medical device demand that produced recent large orders of
- Reports Sixth Consecutive Quarter of Revenue over
-Fiscal First Half Net Income Increases
-Backlog Increased
-Updates FY26 Guidance Reflecting Improved Outlook, Anticipating Modest Revenue Growth with Increasing Demand in the Medical Device Market-
-Conference Call Today at 10:30 am ET-
MILTON, N.Y., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2026, ended August 31, 2025.
Second Quarter Fiscal 2026 Highlights
- Net Sales for the quarter increased to
$5.16 3 million compared to$5.16 2 million year over year and increased sequentially compared to$5.13 million in the first quarter of fiscal 2026. - Gross profit for the quarter increased
3% year over year to$2.6 million compared with$2.5 million . - Net income for the quarter increased
24% to$424 thousand , or$0.03 per share, compared with$341 thousand , or$0.02 per share.
First Half Fiscal 2026 Highlights
- Record first half fiscal 2026 revenue increased year over year to
$10.30 million compared to$10.19 million . - Gross profit increased
6% year over year to$5.3 million compared with$5.0 million , primarily due to product mix and favorable warranty expenses in the current period. - Net income increased
35% year over year to$909 thousand , or$0.06 per share, compared with$672 thousand , or$0.04 per share.
Balance Sheet, Backlog and Guidance for Fiscal Year 2026
- As of August 31, 2025, cash, cash equivalents and marketable securities totaled
$10.6 million with no outstanding debt. - Total equipment and service-related backlog remains strong at
$11.21 million compared to$11.6 million at the end of Q2 FY2025 and increased50% compared to$7.48 million at the end of Q1 FY2026, reflecting new order momentum from the medical market.
- For the full fiscal year, the Company is updating its guidance reflecting an improved outlook anticipating modest revenue growth, balancing a cautious view as the market adjusts to recent shifts in governmental clean energy and tariff policies with a positive offset from growing demand in the medical device market.
Dr. Christopher L. Coccio, Executive Chairman, stated, “We are pleased to report continued growth and profitability in line with our guidance with the continuing trend of over
Steve Harshbarger, CEO & President of Sono-Tek stated, “We continue to see the success of our growth strategies with customers moving into complex large-scale production systems with significantly higher average selling prices “ASPs”. Customer demand and momentum remain strong, and it is validating to see the growing adoption of Sono-Tek’s advanced coating platforms by leading medical device manufacturers worldwide. We are well positioned with our strong balance sheet and backlog to navigate potential short-term demand shifts that may result from changes in tariff policies and clean energy incentives. We remain focused on our long-term growth strategy and look forward to continued revenue growth and profitability over the long term.”
Second Quarter Fiscal 2026 Results
(Narrative compares with prior-year period unless otherwise noted) ($ in thousands)
| Three Months Ended August 31, | Change | ||||||||||||
| 2025 | 2024 | $ | % | ||||||||||
| Net Sales | $ | 5,163 | $ | 5,162 | 1 | ||||||||
| Gross Profit | $ | 2,590 | $ | 2,516 | 74 | ||||||||
| Gross Margin | 50% | 49% | |||||||||||
| Operating Income | $ | 421 | $ | 286 | 135 | ||||||||
| Operating Margin | 8% | 6% | |||||||||||
| Net Income | $ | 424 | $ | 341 | 83 | ||||||||
| Net Margin | 8% | 7% | |||||||||||
- Net Sales:
$5.16 3 million, a slight increase from the$5.16 2 million in the second quarter of fiscal year 2025. This marks the sixth consecutive quarter with sales over$5 million . - Gross Profit:
$2.6 million , up3% from the prior year second quarter of$2.5 million . Gross margin increased to50% from49% , mainly due to a favorable product mix of high ASP systems, reflecting further maturation of our product offerings, with reduced costs and favorable warranty expenses in the current period. - Operating Income: Increased
47% to$421 thousand compared to$286 thousand in the second quarter of fiscal year 2025, due to an increase in gross profit combined with lower operating expenses. - Net Income: Increased
24% to$424 thousand , up from$341 thousand in the second quarter of fiscal year 2025, reflecting a combination of higher gross profit and lower operating expenses. - Other Income: Interest and dividend income decreased slightly to
$82 thousand for the second quarter of fiscal year 2026 from$85 thousand in the second quarter of fiscal year 2025.
Second Quarter Fiscal Year 2026 Product and Market Sales Overview
- Product Categories: In-Line Coating Systems (previously referred to as Integrated Coating Systems) sales decreased by
$493 thousand , or24% , to$1.53 million , primarily driven by a customer-requested delivery delay in the clean energy sector. Multi-Axis Coating Systems increased by$99 thousand , or5% , to$2.03 million . Fluxing sales increased by$46 thousand or39% to$165 thousand , reflecting increased demand from Asia. OEM sales increased by$189 thousand , or92% , to$394 thousand driven by strong fluxer OEMs and two new OEM’s. Spare parts, Services and Other sales increased by$160 thousand , or18% to$1.04 million .- During the current reporting period, the Company updated the title of its product category previously referred to as “Integrated Coating Systems” to “In-Line Coating Systems.” We made this change to provide greater clarity in describing this segment of our business. The definition and contents of this category remain unchanged.
- In-Line Coating Systems include Sono-Tek products that are typically stationary platforms with minimal motion control and may occasionally incorporate a simple axis of movement such as a rotation fixture. These systems are commonly installed over moving substrates such as conveyors or webs, which may be provided either by Sono-Tek or by the customer. They often employ multiple ultrasonic nozzles to provide uniform coverage over larger areas in continuous production environments. In-Line Coating Systems are unlike our Multi-Axis Coating Systems, which commonly utilize XYZ motion platforms or 6+ axis robotic configurations.
- End Markets: The Medical market increased by
150% y-o-y or$602 thousand to$1.00 million , led by balloon coating systems shipped to the U.S., Europe, and China. Alternative/Clean Energy decreased slightly by3% y-o-y or$65 thousand , to$2.43 million , supported by a strong clean energy backlog going into FY 2026. The Electronics market declined slightly by1% y-o-y, down$22 thousand to$1.46 million . The Industrial market declined68% or$517 thousand to$238 thousand , influenced by a large FY 2025 European glass coating order that did not repeat. - Geography: US/Canada sales decreased
22% y-o-y, or$775 thousand , driven by slowing momentum in the US clean energy industry. Offsetting the US sales decline, sales in Asia increased153% y-o-y, or$562 thousand , with major growth in China and other parts of Asia. EMEA sales increased25% , or$288 thousand while Latin American sales were down$74 thousand .
First Half Fiscal Year 2026 Overview
(Narrative compares with prior-year period unless otherwise noted) ($ in thousands)
| Six Months Ended August 31, | Change | ||||||||||||
| 2025 | 2024 | $ | % | ||||||||||
| Net Sales | $ | 10,295 | $ | 10,193 | 102 | ||||||||
| Gross Profit | $ | 5,254 | $ | 4,971 | 283 | ||||||||
| Gross Margin | 51% | 49% | |||||||||||
| Operating Income | $ | 905 | $ | 524 | 381 | ||||||||
| Operating Margin | 9% | 5% | |||||||||||
| Net Income | $ | 909 | $ | 672 | 237 | ||||||||
| Net Margin | 9% | 7% | |||||||||||
- Net Sales:
$10.30 million , an increase from$10.19 million in the first half of fiscal year 2025. - Gross Profit:
$5.3 million , up6% from the first half of fiscal year 2025 of$5 million . Gross margin increased to51% from49% , mainly primarily due to product mix and favorable warranty expenses in the current period. - Operating Income: Increased
73% to$905 thousand compared to$524 thousand in the first half of fiscal year 2025, due to an increase in gross profit combined with lower operating expenses. - Net Income: Increased
35% to$909 thousand , up from$672 thousand in the first half of fiscal year 2025, reflecting a combination of higher gross profit and lower operating expenses. - Other Income: Interest and dividend income decreased slightly to
$224 thousand for the first half of fiscal year 2026 compared to$228 thousand for the first half of fiscal year 2025.
First Half Fiscal Year 2026 Product and Market Sales Overview
- Product Categories: In-Line Coating Systems (previously referred to as Integrated Coating Systems) sales increased by
$1.82 million , or65% , to$4.58 million , driven by shipments of six high-ASP systems to a major solar customer totaling$4.42 million . Fluxing sales increased by$64 thousand or25% driven by strength in Asia. Multi-Axis Coating Systems declined$1.89 million , or41% , to$2.71 million following a strong FY2025 for semiconductor systems that did not repeat, and slower clean energy activity in FY2026. OEM sales were down slightly by$13 thousand or2% and Spare Parts, Services and Other sales were up$126 thousand , a6% increase. - End Markets: The Medical market rose by
44% or$553 thousand , supported by strong balloon coating systems shipped to the U.S., Europe, and China, and increased stent coating activity in Europe. Alternative/Clean Energy rose19% y-o-y, up$901 thousand , driven by the shipment of six high ASP solar coating systems. The Electronics market declined21% y-o-y, down$646 thousand following strong FY2025 semiconductor sales, and FY2026 customer timing for similar machines. The Industrial market declined67% or$711 thousand , influenced by a large FY 2025 European glass coating order that did not repeat. - Geography: US/Canada sales decreased
5% y-o-y, or$324 thousand , driven by slowing momentum in the US clean energy industry. This was offset by increased sales in Asia with74% growth y-o-y, or$647 thousand , led by strong medical sales in China and strong alternative energy sales in Japan and South Korea. EMEA sales declined slightly, declining$60 thousand and Latin American sales down$160 thousand , due to slow fluxing sales in Mexico.
Balance Sheet and Cash Flow Overview
At August 31, 2025, cash, cash equivalents and marketable securities totaled
Capital expenditures in the first half of fiscal 2026 were
Conference Call Information
Sono-Tek will hold a conference call to discuss its second quarter and first half of fiscal year 2026 financial results today, Tuesday, October 14, 2025 at 10:30 am ET. To participate, please call 1-844-481-2752 or 1-412-317-0668 for international callers at least 10 minutes prior to the start of the call and ask to join the Sono-Tek call.
A simultaneous webcast of the call may be accessed through the Company's website, Events & Presentations | Sono-Tek or at https://event.choruscall.com/mediaframe/webcast.html?webcastid=L9LSqRTH
A replay of the call will be available at 1-877-344-7529 or 1-412-317-0088 for international callers, access code 6867548, through October 21, 2025. A replay of the call will also be available on the Company’s website for one year at www.sono-tek.com.
About Sono-Tek
Sono-Tek Corporation (Nasdaq: SOTK) is a global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts in diverse industries including medical devices, semiconductors, microelectronics, alternative energy, advanced industrial manufacturing, and research and development sectors.
Sono-Tek has a long history of providing advanced coating solutions to the medical device industry, enabling precision coatings for life-saving technologies such as stents, balloons, diagnostic devices, and various drug delivery platforms. At the same time, our expertise in semiconductor and microelectronics applications continues to expand, as customers increasingly turn to Sono-Tek for solutions supporting next-generation chips, displays, and sensors. Alongside these markets, our technologies are also leading the way in next-generation clean energy coatings for fuel cells, carbon capture, advanced solar cells, and various other advanced industrial applications, underscoring the versatility and broad reach of Sono-Tek’s ultrasonic coating platforms.
Our product line is rapidly evolving, transitioning from R&D tools to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services ensures unparalleled results for our clients and helps some of the world’s most promising companies achieve technological breakthroughs and bring them to market. The company strategically delivers its products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.
Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com.
Safe Harbor Statement
This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of sales to the medical device market; continued private and public funding for the clean energy sector and continued strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and other markets; maintenance of order backlog; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance. We undertake no obligation to update any forward-looking statement.
For more information:
Sono-Tek Corp.
Stephen J. Bagley
Chief Financial Officer
Ph: (845) 795-2020
info@sono-tek.com
Investor Relations
Kirin Smith
PCG Advisory, Inc.
ksmith@pcgadvisory.com
-FINANCIAL TABLES FOLLOW-
| SONO-TEK CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| August 31, 2025 | February 28, 2025 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 3,832,133 | $ | 5,202,361 | ||||
| Marketable securities | 6,736,469 | 6,727,678 | ||||||
| Accounts receivable (less allowance of | 4,212,354 | 2,347,764 | ||||||
| Inventories | 4,152,027 | 4,474,401 | ||||||
| Prepaid expenses and other current assets | 188,695 | 236,261 | ||||||
| Total current assets | 19,121,678 | 18,988,465 | ||||||
| Land | 250,000 | 250,000 | ||||||
| Buildings, equipment, furnishings and leasehold improvements, net | 2,413,664 | 2,610,600 | ||||||
| Intangible assets, net | 33,529 | 37,386 | ||||||
| Deferred tax asset | 1,366,864 | 1,525,185 | ||||||
| TOTAL ASSETS | $ | 23,185,735 | $ | 23,411,636 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable | $ | 614,512 | $ | 859,483 | ||||
| Accrued expenses | 1,852,959 | 1,718,574 | ||||||
| Customer deposits | 1,906,629 | 2,413,195 | ||||||
| Income taxes payable | 27,813 | 496,055 | ||||||
| Total current liabilities | 4,401,913 | 5,487,307 | ||||||
| Deferred tax liability | 88,153 | 132,134 | ||||||
| Total liabilities | 4,490,066 | 5,619,441 | ||||||
| Commitments and Contingencies (Note 10) | ||||||||
| Stockholders’ Equity | ||||||||
| Common stock, $.01 par value; 25,000,000 shares authorized, 15,751,153 issued and 15,707,062 outstanding as of August 31, 2025 and 15,751,153 issued and 15,749,037 outstanding February 28, 2025, respectively | 157,512 | 157,512 | ||||||
| Additional paid-in capital | 10,163,952 | 10,018,034 | ||||||
| Accumulated earnings | 8,533,194 | 7,624,516 | ||||||
| Treasury stock, at cost, 44,091 shares and 2,116 shares, August 31, 2025 and February 28, 2025, respectively | (158,989 | ) | (7,867 | ) | ||||
| Total stockholders’ equity | 18,695,669 | 17,792,195 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 23,185,735 | $ | 23,411,636 | ||||
| See notes to unaudited condensed consolidated financial statements. | ||||||||
| SONO-TEK CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) | ||||||||||||||||
| Six Months Ended August 31, | Three Months Ended August 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Net Sales | $ | 10,295,469 | $ | 10,192,820 | $ | 5,162,696 | $ | 5,161,782 | ||||||||
| Cost of Goods Sold | 5,041,218 | 5,222,236 | 2,572,959 | 2,645,685 | ||||||||||||
| Gross Profit | 5,254,251 | 4,970,584 | 2,589,737 | 2,516,097 | ||||||||||||
| Operating Expenses | ||||||||||||||||
| Research and product development costs | 1,295,748 | 1,427,303 | 627,278 | 695,873 | ||||||||||||
| Marketing and selling expenses | 1,729,504 | 1,885,608 | 871,353 | 988,418 | ||||||||||||
| General and administrative costs | 1,324,477 | 1,133,387 | 669,952 | 545,816 | ||||||||||||
| Total Operating Expenses | 4,349,729 | 4,446,298 | 2,168,583 | 2,230,107 | ||||||||||||
| Operating Income | 904,522 | 524,286 | 421,154 | 285,990 | ||||||||||||
| Interest and Dividend Income | 223,660 | 227,730 | 81,562 | 85,076 | ||||||||||||
| Net unrealized gain on marketable securities | 1,570 | 53,941 | 23,493 | 43,580 | ||||||||||||
| Income Before Income Taxes | 1,129,752 | 805,957 | 526,209 | 414,646 | ||||||||||||
| Income Tax Expense | 221,074 | 134,435 | 102,516 | 73,961 | ||||||||||||
| Net Income | $ | 908,678 | $ | 671,522 | $ | 423,693 | $ | 340,685 | ||||||||
| Basic Earnings Per Share | $ | 0.06 | $ | 0.04 | $ | 0.03 | $ | 0.02 | ||||||||
| Diluted Earnings Per Share | $ | 0.06 | $ | 0.04 | $ | 0.03 | $ | 0.02 | ||||||||
| Weighted Average Shares - Basic | 15,727,844 | 15,750,895 | 15,721,162 | 15,750,910 | ||||||||||||
| Weighted Average Shares - Diluted | 15,740,384 | 15,771,472 | 15,731,571 | 15,768,251 | ||||||||||||
| See notes to unaudited condensed consolidated financial statements. | ||||||||||||||||
Product Sales
| Three Months Ended August 31, | Change | Six Months Ended August 31, | Change | |||||||||||||||||||||||||||||
| 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | |||||||||||||||||||||||||
| Fluxing Systems | $ | 165,000 | $ | 119,000 | 46,000 | $ | 317,000 | $ | 253,000 | 64,000 | ||||||||||||||||||||||
| In-Line Coating Systems 1 | 1,530,000 | 2,023,000 | (493,000 | ) | ( | ) | 4,584,000 | 2,770,000 | 1,814,000 | |||||||||||||||||||||||
| Multi-Axis Coating Systems | 2,030,000 | 1,931,000 | 99,000 | 2,707,000 | 4,595,000 | (1,888,000 | ) | ( | ) | |||||||||||||||||||||||
| OEM Systems | 394,000 | 205,000 | 189,000 | 524,000 | 537,000 | (13,000 | ) | ( | ) | |||||||||||||||||||||||
| Spare Parts, Services and Other | 1,044,000 | 884,000 | 160,000 | 2,164,000 | 2,038,000 | 126,000 | ||||||||||||||||||||||||||
| TOTAL | $ | 5,163,000 | $ | 5,162,000 | 1,000 | $ | 10,296,000 | $ | 10,193,000 | 103,000 | ||||||||||||||||||||||
- During the current reporting period, the Company updated the title of its product category previously referred to as “Integrated Coating Systems” to “In-Line Coating Systems.” This change was made to provide greater clarity in describing this product line of our business. The definition and contents of this category remain unchanged. In-Line Coating Systems include Sono-Tek products that are typically stationary platforms with minimal motion control, and may occasionally incorporate a simple axis of movement such as a rotation fixture. These systems are commonly installed over moving substrates such as conveyors or webs, which may be provided either by Sono-Tek or by the customer. They often employ multiple ultrasonic nozzles to provide uniform coverage over larger areas in continuous production environments. In-Line Coating Systems are unlike our Multi-Axis Coating Systems, which commonly utilize XYZ motion platforms or 6+ axis robotic configurations.
Market Sales
| Three Months Ended August 31, | Change | Six Months Ended August 31, | Change | |||||||||||||||||||||||||||||
| 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | |||||||||||||||||||||||||
| Electronics/Microelectronics | $ | 1,455,000 | $ | 1,477,000 | (22,000 | ) | ( | ) | $ | 2,399,000 | $ | 3,045,000 | (646,000 | ) | ( | ) | ||||||||||||||||
| Medical | 1,004,000 | 402,000 | 602,000 | 1,812,000 | 1,259,000 | 553,000 | ||||||||||||||||||||||||||
| Alternative/Clean Energy | 2,433,000 | 2,498,000 | (65,000 | ) | ( | ) | 5,681,000 | 4,780,000 | 901,000 | |||||||||||||||||||||||
| Emerging R&D and Other | 33,000 | 30,000 | 3,000 | 47,000 | 41,000 | 6,000 | ||||||||||||||||||||||||||
| Industrial | 238,000 | 755,000 | (517,000 | ) | ( | ) | 357,000 | 1,068,000 | (711,000 | ) | ( | ) | ||||||||||||||||||||
| TOTAL | $ | 5,163,000 | $ | 5,162,000 | 1,000 | $ | 10,296,000 | $ | 10,193,000 | 103,000 | ||||||||||||||||||||||
Geographic Sales
| Three Months Ended August 31, | Change | Six Months Ended August 31, | Change | |||||||||||||||||||||||||||||
| 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | |||||||||||||||||||||||||
| U.S. & Canada | $ | 2,720,000 | $ | 3,495,000 | (775,000 | ) | ( | ) | $ | 6,263,000 | $ | 6,587,000 | (324,000 | ) | ( | ) | ||||||||||||||||
| Asia Pacific (APAC) | 930,000 | 368,000 | 562,000 | 1,527,000 | 880,000 | 647,000 | ||||||||||||||||||||||||||
| Europe, Middle East, Asia (EMEA) | 1,424,000 | 1,136,000 | 288,000 | 2,321,000 | 2,381,000 | (60,000 | ) | ( | ) | |||||||||||||||||||||||
| Latin America | 89,000 | 163,000 | (74,000 | ) | ( | ) | 185,000 | 345,000 | (160,000 | ) | ( | ) | ||||||||||||||||||||
| TOTAL | $ | 5,163,000 | $ | 5,162,000 | 1,000 | $ | 10,296,000 | $ | 10,193,000 | 103,000 | ||||||||||||||||||||||
FAQ
What did Sono-Tek (SOTK) report for fiscal H1 2026 revenue and net income on October 14, 2025?
How large is Sono-Tek's backlog and what drove the increase in Q2 2026 (SOTK)?
What guidance change did Sono-Tek announce on October 14, 2025 for FY26 (SOTK)?
How did Sono-Tek's medical market sales perform in Q2 FY2026 (SOTK)?
What is Sono-Tek's cash and debt position as of August 31, 2025 (SOTK)?
Which product categories showed notable declines in Sono-Tek's Q2 FY2026 results (SOTK)?
